Cyclic DGR-peptidomimetic containing a bicyclic reverse turn inducer as a selective αvβ5 integrin ligand

Amino Acids

Volumn 38, Issue 1, 2010, Pages 329-337

  Trabocchi, A ^a   Menchi, G ^a   Danieli, E ^a   Potenza, D ^b   Cini, N ^a   Bottoncetti, A ^a   Raspanti, S ^a   Pupi, A ^a   Guarna, Antonio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Amino acids; Bicyclic compounds; Conformational analysis; Peptides; Peptidomimetics

Indexed keywords

3 AZA 6,8 DIOXABICYCLO[3.2.1]OCTANE DERIVATIVE; ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; CYCLOPEPTIDE; PEPTIDOMIMETIC AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; BINDING KINETICS; DRUG CONFORMATION; DRUG SYNTHESIS; LIGAND BINDING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

FEMALE; HUMANS; KINETICS; LIGANDS; PEPTIDES, CYCLIC; PLACENTA; PREGNANCY; PROTEIN BINDING; RECEPTORS, VITRONECTIN;

EID: 76449102128     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0255-6     Document Type: Article

References (26)

1. Y Asano H Ihn K Yamane M Kubo K Tamaki 2004 Increased expression levels of integrin {alpha}v{beta}5 on scleroderma fibroblasts Am J Pathol 164 1275 1292 1:CAS:528:DC%2BD2cXjsFemurc%3D 15039216
2. Y Asano H Ihn K Yamane M Jinnin K Tamaki 2006 Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts Am J Pathol 168 499 510 10.2353/ajpath.2006.041306 10.2353/ajpath.2006.041306 1:CAS:528:DC%2BD28Xhs1agurY%3D 16436664 (Pubitemid 43271148)
3. AC Bach II JR Espina SA Jackson PFW Stouten JL Duke SA Mousa WF DeGrado 1996 Type II' to type I β-turn swap changes specificity for integrins J Am Chem Soc 118 293 294 10.1021/ja953163+ 10.1021/ja953163+ 1:CAS:528: DyaK28XltVGjsA%3D%3D (Pubitemid 3017428)
4. VM Belkin AM Belkin VE Koteliansky 1990 Human smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during development J Cell Biol 111 2159 2170 10.1083/jcb.111.5.2159 10.1083/jcb.111.5.2159 1:CAS:528:DyaK3cXlvVyksbk%3D 2229189
5. L Belvisi A Bernardi A Checchia L Manzoni D Potenza C Scolastico M Castorina A Capelli G Giannini P Carminati C Pisano 2001 Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides Org Lett 3 1001 1004 1:CAS:528:DC%2BD3MXhs1ymtLY%3D 11277780
6. L Belvisi T Riccioni M Marcellini L Vesci I Chiarucci D Efrati D Potenza C Scolastico L Manzoni K Lombardo MA Stasi A Orlandi A Ciucci B Nico D Ribatti G Giannini M Presta P Carminati C Pisano 2005 Biological and molecular properties of a new alpha(v)beta(3)/alpha(v)beta(5) integrin antagonist Mol Cancer Ther 4 1670 1680 10.1158/1535-7163.MCT-05-0120 10.1158/1535-7163.MCT-05-0120 1:CAS:528:DC%2BD2MXhtFyrtLvJ 16275988 (Pubitemid 41685301)
7. L Belvisi A Bernardi M Colombo L Manzoni D Potenza C Scolastico G Giannini M Marcellini T Riccioni M Castorina P LoGiudice P Carminati C Pisano 2006 Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acids Bioorg Med Chem 14 169 180 10.1016/j.bmc.2005.08.048 10.1016/j.bmc.2005.08.048 1:CAS:528: DC%2BD2MXht1egsLzF 16214345 (Pubitemid 41635481)
8. Brooks P, Cheresh DA, Friedlander M (1997) Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis. WO 97/06791
9. 5 integrin dual binders J Med Chem 48 7675 7687 10.1021/jm050698x 10.1021/jm050698x 1:CAS:528:DC%2BD2MXhtFOisL3I 16302808 (Pubitemid 41698808)
10. 3 integrin antagonists J Med Chem 42 3033 3040 10.1021/jm970832g 10.1021/jm970832g 1:CAS:528: DyaK1MXksFGhsr0%3D 10447947 (Pubitemid 29384038)
11. A Enns T Korb K Schlüter P Gassmann H-U Spiegel N Senninger F Mitjans J Haier 2005 Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential Eur J Cancer 41 1064 1073 10.1016/j.ejca.2004.12.031 10.1016/j.ejca.2004.12.031 (Pubitemid 40602860)
12. 3 antagonists J Am Chem Soc 118 7461 7472 10.1021/ja9603721 10.1021/ja9603721 1:CAS:528:DyaK28XksFKhtrc%3D (Pubitemid 26279800)
13. RO Hynes 2002 Integrins: bidirectional, allosteric signaling machines Cell 110 673 687 10.1016/S0092-8674(02)00971-6 10.1016/S0092-8674(02)00971-6 1:CAS:528:DC%2BD38XnsFKis70%3D 12297042 (Pubitemid 35283958)
14. V Krchnák J Vágner P Sáfar M Lebl 1988 Noninvasive continuous monitoring of solid phase peptide synthesis by acid-base indicator Collect Czech Chem Commun 53 2542 2548
15. 3 receptor J Pharmacol Exp Ther 283 843 853 1:CAS:528:DyaK2sXnsV2msbY%3D 9353406
16. CC Kumar H Nie L Armstrong R Zhang S Vijay-Kumar A Tsarbopoulos 1998 Chloramine T-induced structural and biochemical changes in echistatin FEBS Lett 429 239 248 10.1016/S0014-5793(98)00587-0 10.1016/S0014-5793(98)00587-0 1:STN:280:DyaK1czisVyjsA%3D%3D 9662425 (Pubitemid 28300368)
17. CC Kumar M Malkowski Z Yin E Tanghetti B Yaremko T Nechuta J Varner M Liu EM Smith B Neustadt M Presta L Armstrong 2001 Inhibition of angiogenesis and tumor growth by SCH221153, a dual α(v)β3 and α(v)β5 integrin receptor antagonist Cancer Res 61 2232 2238 1:CAS:528: DC%2BD3MXit1Ogtrk%3D 11280792
18. E Lohof E Planker C Mang F Burkhart MA Dechantsreiter R Haubner HJ Wester M Schwaiger G Hölzemann SL Goodman H Kessler 2000 Carbohydrate derivatives for use in drug design: cyclic αv-selective RGD peptides Angew Chem Int Ed 39 2761 2764 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0. CO;2-9 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0.CO;2-9 1:CAS:528:DC%2BD3cXmtFCjurg%3D (Pubitemid 30629211)
19. 5: homology modeling and ligand binding J Med Chem 47 4166 4177 10.1021/jm030635j 10.1021/jm030635j 1:CAS:528:DC%2BD2cXlsFemtbc%3D 15293989 (Pubitemid 39045424)
20. 5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the α3 chain of type IV collagen. Implication for the mechanism of endothelial cell adhesion J Biol Chem 279 2772 2780 10.1074/jbc.M311901200 10.1074/jbc.M311901200 1:CAS:528:DC%2BD2cXkslyjtw%3D%3D 14610079 (Pubitemid 38114267)
21. R Pytela MD Pierschbacher S Argraves S Suzuki E Ruoslahti 1987 Arginine-glycine-aspartic acid adhesion receptors Methods Enzymol 144 475 489 10.1016/0076-6879(87)44196-7 10.1016/0076-6879(87)44196-7 1:CAS:528: DyaL1cXjsVCltA%3D%3D 2442581
22. JW Smiths DJ Vestals SV Irwin TA Burke DA Cheresh 1990 Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin J Biol Chem 265 11008 11013
23. 3 integrin antagonists J Med Chem 44 1938 1950 10.1021/jm0004953 10.1021/jm0004953 1:CAS:528:DC%2BD3MXjt1Sgtbk%3D 11384239 (Pubitemid 32884518)
24. A Trabocchi G Menchi M Rolla F Machetti I Bucelli A Guarna 2003 Enantiospecific synthesis of 3-aza-6,8-dioxa-bicyclo[3.2.1]octane carboxylic acids from erythrose Tetrahedron 59 5251 5258 10.1016/S0040-4020(03)00773-7 (Pubitemid 36929748)
25. Trabocchi A, Menchi G, Guarna F, Machetti F, Scarpi D, Guarna A (2006) Design, synthesis, and applications of 3-aza-6,8-dioxabicyclo[3.2.1]octane-based scaffolds for peptidomimetic chemistry. Synlett 331-353
26. 3 in complex with an Arg-Gly-Asp ligand Science 296 151 155 10.1126/science.1069040 (Pubitemid 34280076)